Company profile: PBD Biotech
1.1 - Company Overview
Company description
- Provider of clinical-stage phage-based diagnostics for tuberculosis, developing Actiphage TB, a blood-based test that detects Mycobacterium tuberculosis, supporting latent TB screening, active infection detection, and drug management.
Products and services
- Actiphage Clinical Development: clinical-stage program architects phage-based diagnostics to detect tuberculosis for latent TB screening and drug management applications
- Actiphage TB: phage-based, blood-sample diagnostic test that detects Mycobacterium tuberculosis, indicating active TB infection
- Phage-based Diagnostics R&D: clinical-stage effort engineers phage-based diagnostic products emphasizing tuberculosis detection for latent TB screening and drug management
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PBD Biotech
Hyglos
HQ: Germany
Website
- Description: Provider of bacteriophage-derived recombinant proteins for detection and removal of harmful bacteria, leveraging bacteriophage biochemical principles to develop target-specific protein tools for healthcare applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hyglos company profile →
rqmicro
HQ: Switzerland
Website
- Description: Provider of rapid pathogen separation and detection technology for microbial assessment of water and food, delivering accurate results. Offers rqmicro.COUNT, a portable single-cell counting instrument, a cloud solution to organize microbiology data, application support, and test kits for intact cell count, total cell count, and quantitative E. coli detection in water.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full rqmicro company profile →
Achillion Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies targeting the complement system, including Soliris for paroxysmal nocturnal haemoglobinuria (PNH), atypical haemolytic uraemic syndrome (aHUS) and neuromyelitis optica spectrum disorder; Ultomiris, a long-acting C5 complement inhibitor, for PNH, aHUS, generalised myasthenia gravis and NMOSD; and Strensiq for hypophosphatasia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Achillion Pharmaceuticals company profile →
TriPharm
HQ: United States
Website
- Description: Provider of pharmaceuticals as a privately held pharmaceuticals company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriPharm company profile →
Lodo Therapeutics
HQ: United States
Website
- Description: Provider of drug discovery and development focused on creating naturally derived novel therapeutics to impact global human health, working in partnership with global pharmaceutical companies and leading NGOs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lodo Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PBD Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PBD Biotech
2.2 - Growth funds investing in similar companies to PBD Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PBD Biotech
4.2 - Public trading comparable groups for PBD Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →